| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.8 |